Welcome to the Montreal Children's Hospital
Associate Professor, Department of Neurology and Neurosurgery and Department of Pediatrics, McGill University
Associate member, Department of Epidemiology Biostatistics and Occupational Health
Associate member, Department of Medicine, Division of Experimental Medicine
Evidence-based methodologist, Guideline Development committee, American Academy of Neurology
My clinical research focuses on neuromotor disorders affecting children.
Cerebral palsy, spinal muscular atrophy, epidemiology, neuromuscular
Michelson DJ, Ciafaloni E, Ashwal S, Lewis E, Narayanaswami P, Oskoui M, Armstrong MJ. Evidence in Focus: Nusinersen Use in Spinal Muscular Atrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018 Nov; 91 (20): 923-933. (PMID: 30315070) IF:8.320
Gloss D, Moxley RT 3rd, Ashwal S, Oskoui M. Practice guideline update summary: corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016 Feb; 86(5): 465-72. PubMed ID 26833937
Oskoui M, Gazzellone MJ, Thiruvahindrapuram B, Zarrei M, Andersen J, Wei J, Wang Z, Wintle RF, Marshall CR, Cohn RD, Weksberg R, Stavropoulos DJ, Fehlings D, Shevell MI, Scherer SW. Clinically relevant copy number variations in cerebral palsy. Nat Commun. 2015 Aug 3; 6:7949. Pubmed ID: 26236009.
Oskoui M , Coutinho F , Dykeman J , Jetté N , Pringsheim T. An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Dev Med Child Neurol. 55(6):509-19, 2013 Jun. Epub 2013 Jan 24. PubMed ID: 23346889
Oskoui M , Levy G , Garland CJ , Gray JM , O’Hagen J , De Vivo DC, Kaufmann P. The changing natural history of spinal muscular atrophy type 1. Neurology 69(20):1931-6, 2007 Nov 13. PubMed ID: 17998484